National HealthCare Corporation (NHC)
NYSEAMERICAN: NHC · Real-Time Price · USD
156.00
-11.89 (-7.08%)
Mar 9, 2026, 2:41 PM EDT - Market open
National HealthCare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 1,470 | 1,252 | 1,088 | 1,029 | 965.54 | Upgrade
|
| Other Revenue | 48.15 | 46.18 | 47.7 | 45.2 | 45.4 | Upgrade
|
| Revenue | 1,518 | 1,298 | 1,135 | 1,074 | 1,011 | Upgrade
|
| Revenue Growth (YoY) | 16.94% | 14.32% | 5.68% | 6.26% | 3.38% | Upgrade
|
| Cost of Revenue | 921.08 | 810.93 | 712.34 | 686.17 | 666.06 | Upgrade
|
| Gross Profit | 596.7 | 487.01 | 422.97 | 388.11 | 344.88 | Upgrade
|
| Selling, General & Admin | 46.23 | 43.18 | 41.53 | 40.98 | 40.82 | Upgrade
|
| Other Operating Expenses | 377.2 | 321.39 | 288.18 | 289.37 | 266.75 | Upgrade
|
| Operating Expenses | 468.35 | 406.56 | 371.74 | 370.84 | 348.24 | Upgrade
|
| Operating Income | 128.35 | 80.45 | 51.23 | 17.27 | -3.37 | Upgrade
|
| Interest Expense | -6.37 | -4.14 | -0.32 | -0.56 | -0.85 | Upgrade
|
| Interest & Investment Income | 17.89 | 18.08 | 14.65 | 10.66 | 11.62 | Upgrade
|
| Earnings From Equity Investments | 0.22 | 0.59 | 2.02 | 0.48 | 5.11 | Upgrade
|
| EBT Excluding Unusual Items | 140.09 | 94.98 | 67.56 | 27.85 | 12.52 | Upgrade
|
| Gain (Loss) on Sale of Investments | 22.34 | 31.98 | 14.94 | -15.81 | 82.38 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 6.23 | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -8.23 | Upgrade
|
| Other Unusual Items | - | 9.45 | - | 15.19 | 63.36 | Upgrade
|
| Pretax Income | 162.43 | 136.41 | 88.74 | 27.23 | 150.04 | Upgrade
|
| Income Tax Expense | 39.83 | 34.32 | 23.45 | 7.25 | 10.95 | Upgrade
|
| Earnings From Continuing Operations | 122.61 | 102.09 | 65.29 | 19.98 | 139.09 | Upgrade
|
| Minority Interest in Earnings | -2.59 | -0.16 | 1.51 | 2.47 | -0.5 | Upgrade
|
| Net Income | 120.02 | 101.93 | 66.8 | 22.45 | 138.59 | Upgrade
|
| Net Income to Common | 120.02 | 101.93 | 66.8 | 22.45 | 138.59 | Upgrade
|
| Net Income Growth | 17.75% | 52.59% | 197.61% | -83.80% | 230.99% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 0.31% | 1.44% | -0.45% | 0.20% | 0.31% | Upgrade
|
| EPS (Basic) | 7.76 | 6.62 | 4.36 | 1.46 | 9.03 | Upgrade
|
| EPS (Diluted) | 7.67 | 6.53 | 4.34 | 1.45 | 8.99 | Upgrade
|
| EPS Growth | 17.46% | 50.46% | 199.31% | -83.87% | 230.51% | Upgrade
|
| Free Cash Flow | 148.63 | 79.7 | 83.32 | -21.46 | 23 | Upgrade
|
| Free Cash Flow Per Share | 9.50 | 5.11 | 5.42 | -1.39 | 1.49 | Upgrade
|
| Dividend Per Share | 2.530 | 2.420 | 2.340 | 2.260 | 2.110 | Upgrade
|
| Dividend Growth | 4.54% | 3.42% | 3.54% | 7.11% | 1.44% | Upgrade
|
| Gross Margin | 39.31% | 37.52% | 37.26% | 36.13% | 34.12% | Upgrade
|
| Operating Margin | 8.46% | 6.20% | 4.51% | 1.61% | -0.33% | Upgrade
|
| Profit Margin | 7.91% | 7.85% | 5.88% | 2.09% | 13.71% | Upgrade
|
| Free Cash Flow Margin | 9.79% | 6.14% | 7.34% | -2.00% | 2.27% | Upgrade
|
| EBITDA | 173.27 | 122.44 | 93.26 | 57.76 | 37.31 | Upgrade
|
| EBITDA Margin | 11.42% | 9.43% | 8.21% | 5.38% | 3.69% | Upgrade
|
| D&A For EBITDA | 44.92 | 41.99 | 42.03 | 40.49 | 40.67 | Upgrade
|
| EBIT | 128.35 | 80.45 | 51.23 | 17.27 | -3.37 | Upgrade
|
| EBIT Margin | 8.46% | 6.20% | 4.51% | 1.61% | -0.33% | Upgrade
|
| Effective Tax Rate | 24.52% | 25.16% | 26.43% | 26.64% | 7.30% | Upgrade
|
| Revenue as Reported | 1,518 | 1,307 | 1,142 | 1,086 | 1,074 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.